The Sharjah Clinical Genomics Laboratory in the UK is advancing research and bringing hope to thousands of cancer patients
- A humanitarian initiative by HH Sheikha Jawaher Al Qasimi, the lab was established with a £500,000 donation
- One of only two UK labs selected by NHS England to evaluate long-read whole genome sequencing for clinical application.
- Enhancing lung cancer genetic mutation analysis using ‘Liquid Biopsy’ technology
- Capacity has been doubled to deliver an additional ,000 genetic tests monthly
- Actively participating in clinical trials for DNA-based personalised therapies
- The Royal Marsden is a specialist cancer centre that brings together world class researchers and dedicated clinical teams providing expert compassionate care

Sharjah, August 11, 2025,
The Royal Marsden Cancer Charity; which supports the work of The Royal Marsden; has commended the significant support of Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah and Founder/Royal Patron of the Friends of Cancer Patients (FoCP). Its annual report highlighted her contributions to advancing cancer research, particularly through initiatives over the past five years that have accelerated progress at the Sharjah Clinical Genomics Laboratory within the National Institute for Health and Care Research (NIHR) Centre for Molecular Pathology (CMP); housed within The Royal Marsden in the UK. These efforts have greatly enhanced faster delivery of precise diagnoses and cutting-edge personalised treatments for patients.

The report underscored that Her Highness’s support has empowered the lab’s scientific team to fast-track diagnostics and treatments, bringing hope to thousands of patients. This was achieved through the introduction of state-of-the art facilities to the Sharjah Clinical Genomics Laboratory; including the UK’s first robotic genome testing facility; and bringing together world experts in molecular pathology, bioinformatics, translational research.
Continue reading The Royal Marsden Cancer Charity hails Sheikha Jawaher Al Qasimi’s role in advancing precision medicine for cancer treatment




